Hints and tips:
Related Special Reports
...Soriot is already among the highest-paid bosses in the FTSE with a £16.9mn deal in 2023 and takes home more than the chiefs of European pharmaceutical rivals....
...Although payment reporting standards differ between countries, Soriot receives higher pay than totals reported for other European pharmaceutical executives but is paid slightly less than some US peers....
...Western pharmaceutical companies are in talks with alternative suppliers in response to draft US legislation seeking to restrict an important Chinese drug developer and manufacturer over national security...
...Soriot already earns more than bosses of larger European pharmaceutical companies....
...The company is also a partner for several pharmaceutical companies....
...Fruergaard Jorgensen also said that Novo Nordisk’s efforts to develop some of its oral drugs would require much more active pharmaceutical ingredient than injectables....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
...That holds true for pharmaceutical companies which are looking a bit peaky. Roche, whose stock has fallen 27 per cent in the past 12 months, is a case in point....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...It needs further deals to replenish its pharmaceuticals pipeline....
...The former Roche pharmaceuticals boss took on one of the most unenviable jobs in corporate Europe last June....
...Like many European pharmaceutical companies, it makes a large proportion of sales in the US....
...In February, the UK pharmaceuticals company hit a long-term sales target that once seemed out of reach....
...Ireland’s economy has officially entered recession after contracting by 1.9 per cent in the third quarter, pushed lower by a drop in pharmaceutical exports....
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
...WuXi AppTec is a major supplier of essential ingredients to many of the largest global pharmaceutical companies and conducts drug development for them....
...An Indian pharmaceutical manufacturer, Intas, is a major supplier of finished dosage methotrexate to the US through its subsidiary Accord Healthcare....
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
...referred to in the essay albeit not by name, Samuel P Huntington wrote that “if civilisation is what counts . . . violence between Ukrainians and Russians is unlikely”, being two Slavic, primarily Orthodox...
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...Promises from governments and pharmaceutical companies to boost vaccine equity and pandemic preparedness in anticipation of the next global health crisis have fallen down the political agenda, while disputes...
...According to the European Federation of Pharmaceutical Industries and Associations, a Brussels-based lobby group, the US attracted a third more R&D investment than Europe in 2010....
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
International Edition